A HETEROZYGOUS MUTATION (THE CODON FOR SER447-]A STOP CODON) IN LIPOPROTEIN-LIPASE CONTRIBUTES TO A DEFECT IN LIPID INTERFACE RECOGNITION IN A CASE WITH TYPE-I HYPERLIPIDEMIA

被引:66
作者
KOBAYASHI, J
NISHIDA, T
AMEIS, D
STAHNKE, G
SCHOTZ, MC
HASHIMOTO, H
FUKAMACHI, I
SAITO, KSY
YOSHIDA, S
机构
[1] OTSUKA CELLULAR TECHNOL INST,TOKUSHIMA,JAPAN
[2] UNIV HAMBURG,KRANKENHAUS EPPENDORF,MED KLIN,W-2000 HAMBURG 20,GERMANY
[3] UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA 90024
[4] SHIBAYAGI LAB BIOIMMUNOL SCI,SHIBUKAWA,GUMMA,JAPAN
[5] VET ADM MED CTR BRENTWOOD,LIPID RES,LOS ANGELES,CA 90073
关键词
D O I
10.1016/S0006-291X(05)80113-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previously, we reported a case with type I hyperlipidemia due to a lipid interface recognition deficiency in lipoprotein lipase (LPL) (1). The LPL from postheparin plasma of this patient did not hydrolyze TritonX-100-triolein or very low density lipoprotein-triolein but did hydrolyze tributyrin and LysoPC-triolein substrates Sequence analysis of the proband's DNA revealed a heterozygous nucleotide change: a C→G transversion at position of 1595, resulting in changing the codon for Ser447 to a stop codon. Expression studies of this mutant LPLcDNA in Cos-1 cells produced and secreted considerable amounts of LPL mass in the culture media. The mutated LPL hydrolyzed much less TritonX-100-triolein than wild type LPL, whereas hydrolysis of tributyrin and LysoPC-triolein was the same with both the mutant and wild type LPL. These results suggest that this mutation might be responsible for the property of the LPL with a defect in lipid interface recognition in the type I patient we reported. © 1992 Academic Press, Inc.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 24 条
  • [1] FAMILIAL CHYLOMICRONEMIA (TYPE-I HYPERLIPOPROTEINEMIA) DUE TO A SINGLE MISSENSE MUTATION IN THE LIPOPROTEIN-LIPASE GENE
    AMEIS, D
    KOBAYASHI, J
    DAVIS, RC
    BENZEEV, O
    MALLOY, MJ
    KANE, JP
    LEE, G
    WONG, H
    HAVEL, RJ
    SCHOTZ, MC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) : 1165 - 1170
  • [2] BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P5333
  • [3] LIPOPROTEIN-LIPASE BETHESDA - A SINGLE AMINO-ACID SUBSTITUTION (ALA-176-]THR) LEADS TO ABNORMAL HEPARIN BINDING AND LOSS OF ENZYMATIC-ACTIVITY
    BEG, OU
    MENG, MS
    SKARLATOS, SI
    PREVIATO, L
    BRUNZELL, JD
    BREWER, HB
    FOJO, SS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) : 3474 - 3478
  • [4] LIPOPROTEIN-LIPASE - MODIFICATION OF ITS KINETIC-PROPERTIES BY MILD TRYPTIC DIGESTION
    BENGTSSON, G
    OLIVECRONA, T
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1981, 113 (03): : 547 - 554
  • [5] DEVLIN RH, 1990, AM J HUM GENET, V46, P112
  • [6] EMI M, 1990, J BIOL CHEM, V265, P5910
  • [7] EMI M, 1990, AM J HUM GENET, V47, P107
  • [8] FAUSTINELLA F, 1991, J BIOL CHEM, V266, P14418
  • [9] AN ENZYME-LINKED IMMUNOASSAY FOR LIPOPROTEIN-LIPASE
    GOERS, JWF
    PEDERSEN, ME
    KERN, PA
    ONG, J
    SCHOTZ, MC
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 166 (01) : 27 - 35
  • [10] A HEPATIC LIPASE GENE MUTATION ASSOCIATED WITH HERITABLE LIPOLYTIC DEFICIENCY
    HEGELE, RA
    VEZINA, C
    MOORJANI, S
    LUPIEN, PJ
    GAGNE, C
    BRUN, LD
    LITTLE, JA
    CONNELLY, PW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (03) : 730 - 732